ArticleJournal of clinical medicine2026

Tildrakizumab in Managing Psoriasis with Involvement of Difficult-to-Treat Areas: A Multicenter Real-Life Retrospective Study.

Ruggero Cascio Ingurgio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.